[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Outbreak-Global Cefuximab Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

February 2021 | 113 pages | ID: C42822FED900EN
Maia Research

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Cetuximab is an antibody that acts as an inhibitor of the epidermal growth factor receptor (EGFR). It is used to treat head and neck cancer, metastatic colorectal cancer and metastatic non-small cell lung cancer.

The Cefuximab market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Cefuximab industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Cefuximab market can be split based on product types, major applications, and important countries as follows:

Key players in the global Cefuximab market covered in Chapter 12:

Eli Lilly
Merck

In Chapter 4 and 14.1, on the basis of types, the Cefuximab market from 2015 to 2025 is primarily split into:

100 mg/50 mL Injection
200 mg/100 mL Injection

In Chapter 5 and 14.2, on the basis of applications, the Cefuximab market from 2015 to 2025 covers:

Head and Neck Cancer
Metastatic Colorectal Cancer

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 CEFUXIMAB INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Cefuximab
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Cefuximab industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Cefuximab Market Size, 2015 – 2020
  2.1.2 Global Cefuximab Market Size by Type, 2015 – 2020
  2.1.3 Global Cefuximab Market Size by Application, 2015 – 2020
  2.1.4 Global Cefuximab Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Cefuximab Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Cefuximab Analysis
3.2 Major Players of Cefuximab
3.3 Cefuximab Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Cefuximab
  3.3.3 Labor Cost of Cefuximab
3.4 Market Distributors of Cefuximab
3.5 Major Downstream Buyers of Cefuximab Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL CEFUXIMAB MARKET, BY TYPE

4.1 Global Cefuximab Value and Market Share by Type (2015-2020)
4.2 Global Cefuximab Production and Market Share by Type (2015-2020)
4.3 Global Cefuximab Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Cefuximab Value and Growth Rate of 100 mg/50 mL Injection
  4.3.2 Global Cefuximab Value and Growth Rate of 200 mg/100 mL Injection
4.4 Global Cefuximab Price Analysis by Type (2015-2020)

5 CEFUXIMAB MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Cefuximab Consumption and Market Share by Application (2015-2020)
5.3 Global Cefuximab Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Cefuximab Consumption and Growth Rate of Head and Neck Cancer (2015-2020)
  5.3.2 Global Cefuximab Consumption and Growth Rate of Metastatic Colorectal Cancer (2015-2020)

6 GLOBAL CEFUXIMAB MARKET ANALYSIS BY REGIONS

6.1 Global Cefuximab Sales, Revenue and Market Share by Regions
  6.1.1 Global Cefuximab Sales by Regions (2015-2020)
  6.1.2 Global Cefuximab Revenue by Regions (2015-2020)
6.2 North America Cefuximab Sales and Growth Rate (2015-2020)
6.3 Europe Cefuximab Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Cefuximab Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Cefuximab Sales and Growth Rate (2015-2020)
6.6 South America Cefuximab Sales and Growth Rate (2015-2020)

7 NORTH AMERICA CEFUXIMAB MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Cefuximab Sales, Revenue and Market Share by Countries
  7.2.1 North America Cefuximab Sales by Countries (2015-2020)
  7.2.2 North America Cefuximab Revenue by Countries (2015-2020)
7.3 United States Cefuximab Sales and Growth Rate (2015-2020)
7.4 Canada Cefuximab Sales and Growth Rate (2015-2020)
7.5 Mexico Cefuximab Sales and Growth Rate (2015-2020)

8 EUROPE CEFUXIMAB MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Cefuximab Sales, Revenue and Market Share by Countries
  8.2.1 Europe Cefuximab Sales by Countries (2015-2020)
  8.2.2 Europe Cefuximab Revenue by Countries (2015-2020)
8.3 Germany Cefuximab Sales and Growth Rate (2015-2020)
8.4 UK Cefuximab Sales and Growth Rate (2015-2020)
8.5 France Cefuximab Sales and Growth Rate (2015-2020)
8.6 Italy Cefuximab Sales and Growth Rate (2015-2020)
8.7 Spain Cefuximab Sales and Growth Rate (2015-2020)
8.8 Russia Cefuximab Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC CEFUXIMAB MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Cefuximab Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Cefuximab Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Cefuximab Revenue by Countries (2015-2020)
9.3 China Cefuximab Sales and Growth Rate (2015-2020)
9.4 Japan Cefuximab Sales and Growth Rate (2015-2020)
9.5 South Korea Cefuximab Sales and Growth Rate (2015-2020)
9.6 India Cefuximab Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Cefuximab Sales and Growth Rate (2015-2020)
9.8 Australia Cefuximab Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA CEFUXIMAB MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Cefuximab Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Cefuximab Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Cefuximab Revenue by Countries (2015-2020)
10.3 Saudi Arabia Cefuximab Sales and Growth Rate (2015-2020)
10.4 UAE Cefuximab Sales and Growth Rate (2015-2020)
10.5 Egypt Cefuximab Sales and Growth Rate (2015-2020)
10.6 Nigeria Cefuximab Sales and Growth Rate (2015-2020)
10.7 South Africa Cefuximab Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA CEFUXIMAB MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Cefuximab Sales, Revenue and Market Share by Countries
  11.2.1 South America Cefuximab Sales by Countries (2015-2020)
  11.2.2 South America Cefuximab Revenue by Countries (2015-2020)
11.3 Brazil Cefuximab Sales and Growth Rate (2015-2020)
11.4 Argentina Cefuximab Sales and Growth Rate (2015-2020)
11.5 Columbia Cefuximab Sales and Growth Rate (2015-2020)
11.6 Chile Cefuximab Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Eli Lilly
  12.1.1 Eli Lilly Basic Information
  12.1.2 Cefuximab Product Introduction
  12.1.3 Eli Lilly Production, Value, Price, Gross Margin 2015-2020
12.2 Merck
  12.2.1 Merck Basic Information
  12.2.2 Cefuximab Product Introduction
  12.2.3 Merck Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL CEFUXIMAB MARKET FORECAST

14.1 Global Cefuximab Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 100 mg/50 mL Injection Market Value and Volume Forecast (2020-2025)
  14.1.2 200 mg/100 mL Injection Market Value and Volume Forecast (2020-2025)
14.2 Global Cefuximab Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Head and Neck Cancer Market Value and Volume Forecast (2020-2025)
  14.2.2 Metastatic Colorectal Cancer Market Value and Volume Forecast (2020-2025)
14.3 Cefuximab Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
LIST OF TABLES AND FIGURES

Figure Product Picture of Cefuximab
Table Product Specification of Cefuximab
Table Cefuximab Key Market Segments
Table Key Players Cefuximab Covered
Figure Global Cefuximab Market Size, 2015 – 2025
Table Different Types of Cefuximab
Figure Global Cefuximab Value ($) Segment by Type from 2015-2020
Figure Global Cefuximab Market Share by Types in 2019
Table Different Applications of Cefuximab
Figure Global Cefuximab Value ($) Segment by Applications from 2015-2020
Figure Global Cefuximab Market Share by Applications in 2019
Figure Global Cefuximab Market Share by Regions in 2019
Figure North America Cefuximab Production Value ($) and Growth Rate (2015-2020)
Figure Europe Cefuximab Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Cefuximab Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Cefuximab Production Value ($) and Growth Rate (2015-2020)
Figure South America Cefuximab Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Cefuximab
Table Upstream Raw Material Suppliers of Cefuximab with Contact Information
Table Major Players Headquarters, and Service Area of Cefuximab
Figure Major Players Production Value Market Share of Cefuximab in 2019
Table Major Players Cefuximab Product Types in 2019
Figure Production Process of Cefuximab
Figure Manufacturing Cost Structure of Cefuximab
Figure Channel Status of Cefuximab
Table Major Distributors of Cefuximab with Contact Information
Table Major Downstream Buyers of Cefuximab with Contact Information
Table Global Cefuximab Value ($) by Type (2015-2020)
Table Global Cefuximab Value Share by Type (2015-2020)
Figure Global Cefuximab Value Share by Type (2015-2020)
Table Global Cefuximab Production by Type (2015-2020)
Table Global Cefuximab Production Share by Type (2015-2020)
Figure Global Cefuximab Production Share by Type (2015-2020)
Figure Global Cefuximab Value ($) and Growth Rate of 100 mg/50 mL Injection (2015-2020)
Figure Global Cefuximab Value ($) and Growth Rate of 200 mg/100 mL Injection (2015-2020)
Figure Global Cefuximab Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Cefuximab Consumption by Application (2015-2020)
Table Global Cefuximab Consumption Market Share by Application (2015-2020)
Figure Global Cefuximab Consumption Market Share by Application (2015-2020)
Figure Global Cefuximab Consumption and Growth Rate of Head and Neck Cancer (2015-2020)
Figure Global Cefuximab Consumption and Growth Rate of Metastatic Colorectal Cancer (2015-2020)
Figure Global Cefuximab Sales and Growth Rate (2015-2020)
Figure Global Cefuximab Revenue (M USD) and Growth (2015-2020)
Table Global Cefuximab Sales by Regions (2015-2020)
Table Global Cefuximab Sales Market Share by Regions (2015-2020)
Table Global Cefuximab Revenue (M USD) by Regions (2015-2020)
Table Global Cefuximab Revenue Market Share by Regions (2015-2020)
Table Global Cefuximab Revenue Market Share by Regions in 2015
Table Global Cefuximab Revenue Market Share by Regions in 2019
Figure North America Cefuximab Sales and Growth Rate (2015-2020)
Figure Europe Cefuximab Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Cefuximab Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Cefuximab Sales and Growth Rate (2015-2020)
Figure South America Cefuximab Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Cefuximab Revenue (M USD) and Growth (2015-2020)
Table North America Cefuximab Sales by Countries (2015-2020)
Table North America Cefuximab Sales Market Share by Countries (2015-2020)
Table North America Cefuximab Revenue (M USD) by Countries (2015-2020)
Table North America Cefuximab Revenue Market Share by Countries (2015-2020)
Figure United States Cefuximab Sales and Growth Rate (2015-2020)
Figure Canada Cefuximab Sales and Growth Rate (2015-2020)
Figure Mexico Cefuximab Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Cefuximab Revenue (M USD) and Growth (2015-2020)
Table Europe Cefuximab Sales by Countries (2015-2020)
Table Europe Cefuximab Sales Market Share by Countries (2015-2020)
Table Europe Cefuximab Revenue (M USD) by Countries (2015-2020)
Table Europe Cefuximab Revenue Market Share by Countries (2015-2020)
Figure Germany Cefuximab Sales and Growth Rate (2015-2020)
Figure UK Cefuximab Sales and Growth Rate (2015-2020)
Figure France Cefuximab Sales and Growth (2015-2020)
Figure Italy Cefuximab Sales and Growth (2015-2020)
Figure Spain Cefuximab Sales and Growth (2015-2020)
Figure Russia Cefuximab Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Cefuximab Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Cefuximab Sales by Countries (2015-2020)
Table Asia Pacific Cefuximab Sales Market Share by Countries (2015-2020)
Table Asia Pacific Cefuximab Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Cefuximab Revenue Market Share by Countries (2015-2020)
Figure China Cefuximab Sales and Growth Rate (2015-2020)
Figure Japan Cefuximab Sales and Growth Rate (2015-2020)
Figure South Korea Cefuximab Sales and Growth (2015-2020)
Figure India Cefuximab Sales and Growth (2015-2020)
Figure Southeast Asia Cefuximab Sales and Growth (2015-2020)
Figure Australia Cefuximab Sales and Growth (2015-2020)
Figure Middle East Cefuximab Revenue (M USD) and Growth (2015-2020)
Table Middle East Cefuximab Sales by Countries (2015-2020)
Table Middle East and Africa Cefuximab Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Cefuximab Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Cefuximab Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Cefuximab Sales and Growth Rate (2015-2020)
Figure UAE Cefuximab Sales and Growth Rate (2015-2020)
Figure Egypt Cefuximab Sales and Growth (2015-2020)
Figure Nigeria Cefuximab Sales and Growth (2015-2020)
Figure South Africa Cefuximab Sales and Growth (2015-2020)
Figure South America Cefuximab Revenue (M USD) and Growth (2015-2020)
Table South America Cefuximab Sales by Countries (2015-2020)
Table South America Cefuximab Sales Market Share by Countries (2015-2020)
Table South America Cefuximab Revenue (M USD) by Countries (2015-2020)
Table South America Cefuximab Revenue Market Share by Countries (2015-2020)
Figure Brazil Cefuximab Sales and Growth Rate (2015-2020)
Figure Argentina Cefuximab Sales and Growth Rate (2015-2020)
Figure Columbia Cefuximab Sales and Growth (2015-2020)
Figure Chile Cefuximab Sales and Growth (2015-2020)
Figure Top 3 Market Share of Cefuximab Companies in 2019
Figure Top 6 Market Share of Cefuximab Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Eli Lilly Profile
Table Eli Lilly Product Introduction
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2015-2020
Table Merck Profile
Table Merck Product Introduction
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table Market Driving Factors of Cefuximab
Table Merger, Acquisition and New Investment
Table Global Cefuximab Market Value ($) Forecast, by Type
Table Global Cefuximab Market Volume Forecast, by Type
Figure Global Cefuximab Market Value ($) and Growth Rate Forecast of 100 mg/50 mL Injection (2020-2025)
Figure Global Cefuximab Market Volume ($) and Growth Rate Forecast of 100 mg/50 mL Injection (2020-2025)
Figure Global Cefuximab Market Value ($) and Growth Rate Forecast of 200 mg/100 mL Injection (2020-2025)
Figure Global Cefuximab Market Volume ($) and Growth Rate Forecast of 200 mg/100 mL Injection (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Head and Neck Cancer (2020-2025)
Figure Market Volume and Growth Rate Forecast of Head and Neck Cancer (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Metastatic Colorectal Cancer (2020-2025)
Figure Market Volume and Growth Rate Forecast of Metastatic Colorectal Cancer (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery


More Publications